Results 81 to 90 of about 6,804 (189)

Case Report: Shared manifestation, distinct etiologies: severe pulmonary hypertension in both mother and neonate

open access: yesFrontiers in Pediatrics
BackgroundHereditary hemorrhagic telangiectasia (HHT) is a rare genetic disease. The prevalence of pulmonary arterial hypertension (PAH) in HHT patients is less than 1%.
Sihan Wang   +6 more
doaj   +1 more source

Homoharringtonine promotes heart allograft acceptance by enhancing regulatory T cells induction in a mouse model

open access: yesChinese Medical Journal
. Background:. Homoharringtonine (HHT) is an effective anti-inflammatory, anti-viral, and anti-tumor protein synthesis inhibitor that has been applied clinically.
Xia Qiu   +18 more
doaj   +1 more source

Therapeutic targeting of vascular malformation in a zebrafish model of hereditary haemorrhagic telangiectasia

open access: yesDisease Models & Mechanisms, 2023
Ryan O. Snodgrass   +8 more
doaj   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Reduced DTI-ALPS in H-type hypertension: insights into perivascular space function

open access: yesFrontiers in Neurology
Recent studies suggest that glymphatic dysfunction plays a significant role in vascular cognitive impairment (VCI). Both hypertension and hyperhomocysteinemia are independent risk factors for VCI, and their combination is referred to as H-type ...
Chun Zhang   +6 more
doaj   +1 more source

Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia: Long-term results of endoscopic treatment

open access: yesEndoscopy International Open, 2023
Guido Manfredi   +9 more
doaj   +1 more source

Prevention of serious infections in hereditary hemorrhagic telangiectasia: roles for prophylactic antibiotics, the pulmonary capillaries-but not vaccination

open access: yesHaematologica, 2019
Claire Shovlin   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy